Matches in SemOpenAlex for { <https://semopenalex.org/work/W3020241738> ?p ?o ?g. }
- W3020241738 endingPage "1087" @default.
- W3020241738 startingPage "1087" @default.
- W3020241738 abstract "Triple negative breast cancer is a collection of heterogeneous breast cancers that are immunohistochemically negative for estrogen receptor, progesterone receptor, and ErbB2 (due to deletion or lack of amplification). No dominant proliferative driver has been identified for this type of cancer, and effective targeted therapy is lacking. In this study, we hypothesized that triple negative breast cancer cells are multi-driver cancer cells, and evaluated a biphasic mathematical model for identifying potent and synergistic drug combinations for multi-driver cancer cells. The responses of two triple negative breast cancer cell lines, MDA-MB-231 and MDA-MB-468, to a panel of targeted therapy drugs were determined over a broad range of concentrations. The analyses of the drug responses by the biphasic mathematical model revealed that both cell lines were indeed dependent on multiple drivers, and inhibitors of individual drivers caused a biphasic response: a target-specific partial inhibition at low nM concentrations, and an off-target toxicity at μM concentrations. We further demonstrated that combinations of drugs, targeting each driver, cause potent, synergistic, and cell-specific cell killing. Immunoblotting analysis of the effects of the individual drugs and drug combinations on the signaling pathways supports the above conclusion. These results support a multi-driver proliferation hypothesis for these triple negative breast cancer cells, and demonstrate the applicability of the biphasic mathematical model for identifying effective and synergistic targeted drug combinations for triple negative breast cancer cells." @default.
- W3020241738 created "2020-05-01" @default.
- W3020241738 creator A5019236716 @default.
- W3020241738 creator A5020060083 @default.
- W3020241738 creator A5038668782 @default.
- W3020241738 creator A5053017129 @default.
- W3020241738 creator A5088287086 @default.
- W3020241738 date "2020-04-27" @default.
- W3020241738 modified "2023-09-25" @default.
- W3020241738 title "Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells" @default.
- W3020241738 cites W1498424378 @default.
- W3020241738 cites W1555009525 @default.
- W3020241738 cites W1558515869 @default.
- W3020241738 cites W1594706458 @default.
- W3020241738 cites W1619850371 @default.
- W3020241738 cites W1986366957 @default.
- W3020241738 cites W1988698939 @default.
- W3020241738 cites W1994448145 @default.
- W3020241738 cites W1994663540 @default.
- W3020241738 cites W2000302922 @default.
- W3020241738 cites W2003973314 @default.
- W3020241738 cites W2014673454 @default.
- W3020241738 cites W2015309828 @default.
- W3020241738 cites W2032225894 @default.
- W3020241738 cites W2041118166 @default.
- W3020241738 cites W2044702943 @default.
- W3020241738 cites W2066003961 @default.
- W3020241738 cites W2078448804 @default.
- W3020241738 cites W2087312216 @default.
- W3020241738 cites W2093345318 @default.
- W3020241738 cites W2096283457 @default.
- W3020241738 cites W2096439168 @default.
- W3020241738 cites W2097208900 @default.
- W3020241738 cites W2117497402 @default.
- W3020241738 cites W2126928912 @default.
- W3020241738 cites W2135429827 @default.
- W3020241738 cites W2139639159 @default.
- W3020241738 cites W2142577868 @default.
- W3020241738 cites W2144831154 @default.
- W3020241738 cites W2153189553 @default.
- W3020241738 cites W2160703426 @default.
- W3020241738 cites W2161975859 @default.
- W3020241738 cites W2164568999 @default.
- W3020241738 cites W2170292198 @default.
- W3020241738 cites W2171554194 @default.
- W3020241738 cites W2184278156 @default.
- W3020241738 cites W2275209600 @default.
- W3020241738 cites W2280154192 @default.
- W3020241738 cites W2299417213 @default.
- W3020241738 cites W2402636472 @default.
- W3020241738 cites W2403180641 @default.
- W3020241738 cites W2421926727 @default.
- W3020241738 cites W2520018761 @default.
- W3020241738 cites W2535405120 @default.
- W3020241738 cites W2547455704 @default.
- W3020241738 cites W2552223059 @default.
- W3020241738 cites W2554598612 @default.
- W3020241738 cites W2558715006 @default.
- W3020241738 cites W2560367415 @default.
- W3020241738 cites W2585573922 @default.
- W3020241738 cites W2606513998 @default.
- W3020241738 cites W2608863179 @default.
- W3020241738 cites W2738609359 @default.
- W3020241738 cites W2765386661 @default.
- W3020241738 cites W2774112395 @default.
- W3020241738 cites W2792243488 @default.
- W3020241738 cites W2891443826 @default.
- W3020241738 cites W2904991649 @default.
- W3020241738 cites W2910100149 @default.
- W3020241738 cites W2910846947 @default.
- W3020241738 cites W2912784440 @default.
- W3020241738 cites W2912993657 @default.
- W3020241738 cites W2936978491 @default.
- W3020241738 cites W2951449549 @default.
- W3020241738 cites W2955973158 @default.
- W3020241738 cites W2981597895 @default.
- W3020241738 cites W3002547690 @default.
- W3020241738 cites W3005762093 @default.
- W3020241738 cites W4211032970 @default.
- W3020241738 doi "https://doi.org/10.3390/cancers12051087" @default.
- W3020241738 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7281712" @default.
- W3020241738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32349331" @default.
- W3020241738 hasPublicationYear "2020" @default.
- W3020241738 type Work @default.
- W3020241738 sameAs 3020241738 @default.
- W3020241738 citedByCount "4" @default.
- W3020241738 countsByYear W30202417382022 @default.
- W3020241738 countsByYear W30202417382023 @default.
- W3020241738 crossrefType "journal-article" @default.
- W3020241738 hasAuthorship W3020241738A5019236716 @default.
- W3020241738 hasAuthorship W3020241738A5020060083 @default.
- W3020241738 hasAuthorship W3020241738A5038668782 @default.
- W3020241738 hasAuthorship W3020241738A5053017129 @default.
- W3020241738 hasAuthorship W3020241738A5088287086 @default.
- W3020241738 hasBestOaLocation W30202417381 @default.
- W3020241738 hasConcept C121608353 @default.
- W3020241738 hasConcept C126322002 @default.
- W3020241738 hasConcept C2780035454 @default.